0000950170-23-040843.txt : 20230809
0000950170-23-040843.hdr.sgml : 20230809
20230809192346
ACCESSION NUMBER: 0000950170-23-040843
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230809
DATE AS OF CHANGE: 20230809
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Pharvaris N.V.
CENTRAL INDEX KEY: 0001830487
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40010
FILM NUMBER: 231156733
BUSINESS ADDRESS:
STREET 1: J.H. OORTWEG 21
STREET 2: 2333 CH LEIDEN
CITY: LEIDEN
STATE: P7
ZIP: 00000
BUSINESS PHONE: 31 (0)71 203 6410
MAIL ADDRESS:
STREET 1: J.H. OORTWEG 21
STREET 2: 2333 CH LEIDEN
CITY: LEIDEN
STATE: P7
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: Pharvaris, B.V.
DATE OF NAME CHANGE: 20201029
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Modig Berndt
CENTRAL INDEX KEY: 0001643072
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 1441 BROADWAY, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
144
1
primary_doc.xml
144
0001643072
XXXXXXXX
LIVE
0001830487
Pharvaris N.V.
001-40010
Emmy Noetherweg 2, 2333 BK
Leiden
P7
00000
31-(0)71 2036 410
Berndt Modig
CEO
Ordinary Shares, par value 0.12 per share
CS Securities USA LLC
Eleven Madison Avenue
New York
NY
10010-3623
15000
265650
40822916
08/09/2023
Nasdaq
Ordinary Shares, par value 0.12 per share
CS Securities USA LLC
Eleven Madison Avenue
New York
NY
10010-3623
40000
708400
40822916
08/09/2023
Nasdaq
Ordinary Shares, par value 0.12 per share
CS Securities USA LLC
Eleven Madison Avenue
New York
NY
10010-3623
30000
531300
40822916
08/09/2023
Nasdaq
Ordinary Shares, par value 0.12 per share
CS Securities USA LLC
Eleven Madison Avenue
New York
NY
10010-3623
40000
708400
40822916
08/09/2023
Nasdaq
Ordinary Shares, par value Euro 0.12 per share
01/01/2020
Vested stock options
Pharvaris N.V.
N
125000
01/01/2020
Services rendered
Y
08/09/2023
05/11/2023
/s/ Berndt Modig